selected publications
-
academic article
- Association of Anticoagulant Choice on mortality in the Primary Treatment of Non-Cancer Venous Thromboembolism: Medicare 2011-2018.. American journal of epidemiology. 2024
- Autoimmune disease and risk of postpartum venous thromboembolism.. Research and practice in thrombosis and haemostasis. 7:-. 2023
- Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database.. BMC cardiovascular disorders. 21:-. 2021
- Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018.. Journal of the American Heart Association. 10:-. 2021
- Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism.. Journal of the American Heart Association. 10:-. 2021
- Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.. JAMA internal medicine. 180:245-253. 2020
- Diagnosed Sleep Apnea and Cardiovascular Disease in Atrial Fibrillation Patients: The Role of Measurement Error from Administrative Data.. Epidemiology (Cambridge, Mass.). 30:885-892. 2019
- Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation.. PloS one. 14:-. 2019
- Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism.. British journal of haematology. 185:903-911. 2019
- A new model to predict ischemic stroke in patients with atrial fibrillation using warfarin or direct oral anticoagulants.. Heart rhythm. 16:820-826. 2018
- Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients.. Current medical research and opinion. 35:837-845. 2018
- Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation.. Journal of the American Heart Association. 7:-. 2018
- Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.. Journal of the American College of Cardiology. 72:1913-1922. 2018
- A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants.. PloS one. 13:-. 2018
- Influence of Sociodemographic Factors and Provider Specialty on Anticoagulation Prescription Fill Patterns and Outcomes in Atrial Fibrillation.. The American journal of cardiology. 122:388-394. 2018
- Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.. Journal of the American Heart Association. 7. 2018
- Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation.. Blood advances. 2:200-209. 2018
- Oral anticoagulants and liver injury: the threat of uncontrolled confounding.. Heart (British Cardiac Society). 104:-. 2018
- Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.. BMC cardiovascular disorders. 17:-. 2017
- Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation.. Heart (British Cardiac Society). 103:834-839. 2017
- Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC).. PloS one. 11:-. 2016